Fey, Martin

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2024 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 1999 | 1998 | 1997 | 1996 | 1994

2024

Fey, Martin (2024). The GLOW trial in chronic lymphocytic leukaemia. The Lancet. Oncology, 25(2) Elsevier 10.1016/S1470-2045(23)00620-4

2021

Eychmüller, Steffen; Zwahlen, Susanne; Fliedner, Monika; Jüni, Peter; Aebersold, Daniel; Aujesky, Drahomir; Fey, Martin; Maessen, Maud; Trelle, Sven (2021). Single early palliative care intervention added to usual oncology care for patients with advanced cancer: A randomized controlled trial (SENS Trial). Palliative medicine, 35(6), pp. 1108-1117. Sage 10.1177/02692163211005340

2020

von Wolff, Michael; Fey, Martin F. (2020). Other Malignancies. In: von Wolff, Michael; Nawroth, Frank (eds.) Fertility Preservation in Oncological and Non-Oncological Diseases (pp. 105-113). Cham: Springer 10.1007/978-3-030-47568-0_13

2018

Eychmüller, Steffen; Zwahlen, Susanne; Fliedner, Monica; Trelle, Sven; Maessen, Maud; Aebersold, Daniel; Aujesky, Drahomir; Fey, Martin; Jüni, Peter (April 2018). A Structured Early Palliative Care Intervention for Patients with Advanced Cancer - A Randomized Controlled Trial. Palliative medicine, 32(1_suppl), p. 17. Sage

Schüring, A N; Fehm, T; Behringer, K; Goeckenjan, M; Wimberger, P; Henes, M; Henes, J; Fey, Martin; von Wolff, Michael (2018). Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation. Archives of gynecology and obstetrics, 297(1), pp. 241-255. Springer 10.1007/s00404-017-4594-3

2017

Metzelder, S K; Schroeder, T; Lübbert, M; Ditschkowski, M; Götze, K; Scholl, S; Meyer, R G; Dreger, P; Basara, N; Fey, Martin; Salih, H R; Finck, A; Pabst, Thomas; Giagounidis, A; Kobbe, G; Wollmer, E; Finke, J; Neubauer, A; Burchert, A (2017). Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation. European journal of cancer, 86, pp. 233-239. Elsevier 10.1016/j.ejca.2017.09.016

Fey, Martin (2017). The costs of care in haematological cancers: Health economic issues. Hematological oncology, 35(S1), pp. 15-19. Wiley 10.1002/hon.2394

Rothschild, Sacha; Gautschi, Oliver; Batliner, Jasmin; Gugger, Mathias; Fey, Martin; Tschan, Mario (2017). MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors. Lung cancer, 107, pp. 73-83. Elsevier 10.1016/j.lungcan.2016.06.004

2016

Wampfler, Julian; Federzoni, Elena; Torbett, Bruce E; Fey, Martin; Tschan, Mario (2016). The RNA binding proteins RBM38 and DND1 are repressed in AML and have a novel function in APL differentiation. Leukemia research, 41, pp. 96-102. Elsevier 10.1016/j.leukres.2015.12.006

2015

Wampfler, Julian; Federzoni, Elena; Torbett, Bruce E; Fey, Martin; Tschan, Mario (2015). Low DICER1 expression is associated with attenuated neutrophil differentiation and autophagy of NB4 APL cells. Journal of leukocyte biology, 98(3), pp. 357-363. Society for Leukocyte Biology 10.1189/jlb.1AB0514-258R

Vidal, A D; Thalmann, George; Karamitopoulou, Evanthia; Fey, Martin; Studer, Urs (2015). Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy. Annals of oncology, 26(2), pp. 374-377. Oxford University Press 10.1093/annonc/mdu518

Cornelissen, J J; Versluis, J; Passweg, Jakob; van Putten, W L J; Manz, M G; Maertens, J; Beverloo, H B; Valk, P J M; van Marwijk Kooy, M; Wijermans, P W; Schaafsma, M R; Biemond, B J; Vekemans, M-C; Breems, D A; Verdonck, L F; Fey, Martin; Jongen-Lavrencic, M; Janssen, J J W M; Huls, G; Kuball, J; ... (2015). Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia, 29(5), pp. 1041-1050. Nature Publishing Group 10.1038/leu.2014.332

Federzoni, Elena; Gloor, Severin; Jin, Jing; Krauer, Deborah; Fey, Martin; Torbett, Bruce E; Tschan, Mario (2015). Linking the SUMO protease SENP5 to neutrophil differentiation of AML cells. Leukemia research reports, 4(1), pp. 32-35. Elsevier 10.1016/j.lrr.2015.04.002

2014

Haimovici, Aladin; Brigger, Daniel; Torbett, Bruce E; Fey, Martin; Tschan, Mario (2014). Induction of the autophagy-associated gene MAP1S via PU.1 supports APL differentiation. Leukemia research, 38(9), pp. 1041-1047. Elsevier 10.1016/j.leukres.2014.06.010

Bohlius, J; Tonia, T; Nüesch, E; Jüni, P; Fey, M F; Egger, M; Bernhard, J (2014). Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data. British journal of cancer, 111(1), pp. 33-45. Nature Publishing Group 10.1038/bjc.2014.171

Stutz, Emanuel; Gautschi, Oliver; Fey, Martin F.; Gugger, Mathias; Tschan, Mario; Rothschild, Sacha I. (2014). Crizotinib inhibits migration and expression of ID1 in MET-positive lung cancer cells: implications for MET targeting in oncology. Future oncology, 10(2), pp. 211-217. Future Medicine Ltd. 10.2217/fon.13.179

Humbert, Magali; Federzoni, Elena; Britschgi, Adrian; Schläfli, Anna; Valk, PJ; Kaufmann, Thomas; Haferlach, T.; Behre, G.; Simon, Hans-Uwe; Torbett, BE; Fey, Martin; Tschan, Mario (2014). The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL. Journal of leukocyte biology, 95(1), pp. 83-93. Society for Leukocyte Biology 10.1189/jlb.1112608

Federzoni, Elena; Humbert, Magali; Torbett, Bruce E; Behre, Gerhard; Fey, Martin; Tschan, Mario (2014). CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation. Scientific Reports, 4(1), p. 4261. Nature Publishing Group 10.1038/srep04261

2013

Humbert, Magali; Medova, Michaela; Aebersold, Daniel; Blaukat, Andree; Bladt, Friedhelm; Fey, Martin; Zimmer, Yitzhak; Tschan, Mario P. (2013). Protective autophagy is involved in resistance towards MET inhibitors in human gastric adenocarcinoma cells. Biochemical and biophysical research communications, 431(2), pp. 264-269. Academic Press 10.1016/j.bbrc.2012.12.120

Fey, Martin; Buske, C. (2013). Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 24(6), vi138-vi143. Oxford University Press 10.1093/annonc/mdt320

Brigger, Daniel; Torbett, Bruce E.; Chen, Joy; Fey, Martin; Tschan, Mario (2013). Inhibition of GATE-16 attenuates ATRA-induced neutrophil differentiation of APL cells and interferes with autophagosome formation. Biochemical and biophysical research communications, 438(2), pp. 283-288. Academic Press 10.1016/j.bbrc.2013.07.056

Federzoni, Elena A.; Humbert, Magali; Valk, Peter J. M.; Behre, Gerhard; Leibundgut, Elisabeth O.; Torbett, Bruce E; Fey, Martin F.; Tschan, Mario (2013). The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients. British journal of haematology, 160(6), pp. 855-859. Oxford: Wiley-Blackwell 10.1111/bjh.12170

2012

Salemi, Souzan; Yousefi, Shida; Constantinescu, Mihai A; Fey, Martin F; Simon, Hans-Uwe (2012). Autophagy is required for self-renewal and differentiation of adult human stem cells. Cell research, 22(2), pp. 432-5. London: Nature Publishing Group 10.1038/cr.2011.200

Batliner, Jasmin; Buehrer, Emanuel; Federzoni, Elena A; Jenal, Mathias; Tobler, Andreas; Torbett, Bruce E; Fey, Martin F; Tschan, Mario P (2012). Transcriptional regulation of MIR29B by PU.1 (SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells. British journal of haematology, 157(2), pp. 270-274. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2011.08964.x

Batliner, Jasmin; Buehrer, Emanuel; Fey, Martin F; Tschan, Mario P (2012). Inhibition of the miR-143/145 cluster attenuated neutrophil differentiation of APL cells. Leukemia research, 36(2), pp. 237-40. Amsterdam: Elsevier 10.1016/j.leukres.2011.10.006

Rothschild, S I; Tschan, M P; Federzoni, E A; Jaggi, R; Fey, M F; Gugger, M; Gautschi, O (2012). MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma. Oncogene, 31(38), pp. 4221-32. Basingstoke, UK: Nature Publishing Group 10.1038/onc.2011.578

Burmeister, H; Aebi, S; Studer, C; Fey, M.F.; Gautschi, O (2012). Adherence to ESMO clinial recommendations for prophylaxis of chemotherapy-induced nausea and vomiting. Supportive care in cancer, 20(1), pp. 141-7. Berlin: Springer 10.1007/s00520-010-1079-3

Rothschild, Sacha I; Tschan, Mario P; Jaggi, Rolf; Fey, Martin F; Gugger, Mathias; Gautschi, Oliver (2012). MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma. Journal of thoracic oncology, 7(7), pp. 1069-77. Hagerstown, Md.: Wolters Kluwer Health/Lippincott Williams & Wilkins 10.1097/JTO.0b013e31824fe976

Metzelder, S K; Schroeder, T; Finck, A; Scholl, S; Fey, M; Götze, K; Linn, Y C; Kröger, M; Reiter, A; Salih, H R; Heinicke, T; Stuhlmann, R; Müller, L; Giagounidis, A; Meyer, R G; Brugger, W; Vöhringer, M; Dreger, P; Mori, M; Basara, N; ... (2012). High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses. Leukemia, 26(11), pp. 2353-2359. Basingstoke: Nature Publishing Group 10.1038/leu.2012.105

Federzoni, Elena A; Valk, Peter J M; Torbett, Bruce E; Haferlach, Torsten; Löwenberg, Bob; Fey, Martin F; Tschan, Mario P (2012). PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells. Blood, 119(21), pp. 4963-70. Washington, D.C.: American Society of Hematology 10.1182/blood-2011-09-378117

Schläfli, Anna; Torbett, Bruce E.; Fey, Martin F.; Tschan, Mario P. (2012). BIRC6 (APOLLON) is down-regulated in acute myeloid leukemia and its knockdown attenuates neutrophil differentiation. Experimental hematology & oncology, 1(1), p. 25. London: Biomed Central 10.1186/2162-3619-1-25

Humbert, Magali; Mueller, Chantal; Fey, Martin F; Tschan, Mario P (2012). Inhibition of damage-regulated autophagy modulator-1 (DRAM-1) impairs neutrophil differentiation of NB4 APL cells. Leukemia research, 36(12), pp. 1552-6. Amsterdam: Elsevier 10.1016/j.leukres.2012.08.024

2011

Batliner, Jasmin; Mancarelli, Maria Michela; Jenal, Mathias; Reddy, Venkateshwar A; Fey, Martin F; Torbett, Bruce E; Tschan, Mario P (2011). CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation. Molecular immunology, 48(4), pp. 714-9. Amsterdam: Elsevier 10.1016/j.molimm.2010.10.016

Humbert, Magali; Halter, Veronika; Shan, Deborah; Laedrach, Judith; Leibundgut, Elisabeth Oppliger; Baerlocher, Gabriela M; Tobler, Andreas; Fey, Martin F; Tschan, Mario P (2011). Deregulated expression of Kruppel-like factors in acute myeloid leukemia. Leukemia research, 35(7), pp. 909-13. Amsterdam: Elsevier 10.1016/j.leukres.2011.03.010

Fey, Martin F; Tobler, Andreas (2011). Marriage risk of cancer research fellows. Lancet, 378(9809), p. 2070. London: Elsevier 10.1016/S0140-6736(11)61898-9

Fey, ; Martin, F (2011). [Recombinant proteins as therapeutic compounds in clinical oncology]. Therapeutische Umschau, 68(11), pp. 618-30. Bern: Huber 10.1024/0040-5930/a000222

Vellenga, Edo; van Putten, Wim; Ossenkoppele, Gert J; Verdonck, Leo F; Theobald, Matthias; Cornelissen, Jan J; Huijgens, Peter C; Maertens, Johan; Gratwohl, Alois; Schaafsma, Ron; Schanz, Urs; Graux, Carlos; Schouten, Harry C; Ferrant, Augustin; Bargetzi, Mario; Fey, Martin F; Löwenberg, Bob; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), ; Swiss Group for Clinical Cancer Research Collaborative Group (SA, (2011). Autologous peripheral blood stem cell transplantation for acute myeloid leukemia. Blood, 118(23), pp. 6037-42. Washington, D.C.: American Society of Hematology 10.1182/blood-2011-07-370247

Fey, M. F. (2011). VI. DNA microarray technology. Principles and application to the analysis of malignant tumours (with special emphasis on lymphoma). Annals of oncology, 22(Suppl. 4), iv44-iv46. Oxford University Press 10.1093/annonc/mdr172

2010

Jenal, M; Batliner, J; Reddy, V A; Haferlach, T; Tobler, A; Fey, M F; Torbett, B E; Tschan, M P (2010). The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1. Leukemia, 24(5), pp. 1073-6. Basingstoke: Nature Publishing Group 10.1038/leu.2010.26

Britschgi, Adrian; Simon, Hans-Uwe; Tobler, Andreas; Fey, Martin F; Tschan, Mario P (2010). Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2. British journal of haematology, 149(1), pp. 55-64. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2009.08040.x

Jenal, Mathias; Britschgi, Christian; Fey, Martin F; Tschan, Mario P (2010). Inactivation of the hypermethylated in cancer 1 tumour suppressor--not just a question of promoter hypermethylation? Swiss medical weekly, 140, w13106. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13106

Fey, Martin (2010). Lymphoma--a topic with seven seals. Therapeutische Umschau, 67(10), p. 489. Bern: Huber

Fey, Martin (2010). Salient clinical features of lymphoma and related lymphoproliferative disorders. Therapeutische Umschau, 67(10), pp. 491-495. Bern: Huber 10.1024/0040-5930/a000083

Fey, M F; Dreyling, M (2010). Acute myeloblastic leukaemias and myelodysplastic syndromes in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 21 Suppl 5, v158-v161. Oxford: Oxford University Press 10.1093/annonc/mdq179

Tschan, Mario P; Shan, Deborah; Laedrach, Judith; Eyholzer, Marianne; Leibundgut, Elisabeth Oppliger; Baerlocher, Gabriela M; Tobler, Andreas; Stroka, Deborah; Fey, Martin F (2010). NDRG1/2 expression is inhibited in primary acute myeloid leukemia. Leukemia research, 34(3), pp. 393-8. Amsterdam: Elsevier 10.1016/j.leukres.2009.08.037

2009

Pagani, Olivia; Gelber, Shari; Simoncini, Edda; Castiglione-Gertsch, Monica; Price, Karen; Gelber, Richard; Holmberg, Stig; Crivellari, Diana; Collins, John; Lindtner, Jurij; Thürlimann, Beat; Fey, Martin; Murray, Elizabeth; Forbes, John; Coates, Alan; Goldhirsch, Aron (2009). Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93. Breast cancer research and treatment, 116(3), pp. 491-500. Dordrecht: Springer 10.1007/s10549-008-0225-9

Bohlius, Julia; Schmidlin, Kurt; Brillant, Corinne; Schwarzer, Guido; Trelle, Sven; Seidenfeld, Jerome; Zwahlen, Marcel; Clarke, Mike J; Weingart, Olaf; Kluge, Sabine; Piper, Margaret; Napoli, Maryann; Rades, Dirk; Steensma, David; Djulbegovic, Benjamin; Fey, Martin F; Ray-Coquard, Isabelle; Moebus, Volker; Thomas, Gillian; Untch, Michael; ... (2009). Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data. Cochrane database of systematic reviews, 2009(3), CD007303. Chichester: WileyInterscience 10.1002/14651858.CD007303.pub2

Bohlius, Julia; Schmidlin, Kurt; Brillant, Corinne; Schwarzer, Guido; Trelle, Sven; Seidenfeld, Jerome; Zwahlen, Marcel; Clarke, Michael; Weingart, Olaf; Kluge, Sabine; Piper, Margaret; Rades, Dirk; Steensma, David P; Djulbegovic, Benjamin; Fey, Martin F; Ray-Coquard, Isabelle; Machtay, Mitchell; Moebus, Volker; Thomas, Gillian; Untch, Michael; ... (2009). Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet, 373(9674), pp. 1532-42. London: Elsevier 10.1016/S0140-6736(09)60502-X

Andina, N; Conus, S; Schneider, E M; Fey, M F; Simon, H U (2009). Induction of Bim limits cytokine-mediated prolonged survival of neutrophils. Cell death and differentiation, 16(9), pp. 1248-55. Basingstoke: Nature Publishing Group 10.1038/cdd.2009.50

Wampfler, Julian; Tschan, Mario P; Shan, Deborah; Laemmle, Alexander; Leibundgut, Elisabeth O; Baerlocher, Gabriela M; Stroka, Deborah; Fey, Martin F; Britschgi, Christian (2009). SIRT1 is downregulated during neutrophil differentiation of acute promyelocytic leukaemia cells. British journal of haematology, 146(3), pp. 337-41. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2009.07749.x

Britschgi, Christian; Fey, Martin F (2009). Tumor suppressor genes in myeloid differentiation and leukemogenesis. Future oncology, 5(2), pp. 245-57. London: Future Medicine Ltd. 10.2217/14796694.5.2.245

Fey, M; Dreyling, M (2009). Acute myeloblastic leukemia in adult patients: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology, 20 Suppl 4, pp. 100-101. Oxford: Oxford University Press 10.1093/annonc/mdp141

Pagani, Olivia; Price, Karen N; Gelber, Richard D; Castiglione-Gertsch, Monica; Holmberg, Stig B; Lindtner, Jurij; Thürlimann, Beat; Collins, John; Fey, Martin F; Coates, Alan S; Goldhirsch, Aron (2009). Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century. Breast cancer research and treatment, 117(2), pp. 319-24. Dordrecht: Springer 10.1007/s10549-008-0282-0

Jenal, Mathias; Trinh, Emmanuelle; Britschgi, Christian; Britschgi, Adrian; Roh, Vincent; Vorburger, Stephan A; Tobler, Andreas; Leprince, Dominique; Fey, Martin F; Helin, Kristian; Tschan, Mario P (2009). The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1. Molecular cancer research, 7(6), pp. 916-22. Philadelphia, Pa.: American Association for Cancer Research AACR 10.1158/1541-7786.MCR-08-0359

2008

Britschgi, A; Trinh, E; Rizzi, M; Jenal, M; Ress, A; Tobler, A; Fey, M F; Helin, K; Tschan, M P (2008). DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function. Oncogene, 27(43), pp. 5706-16. Basingstoke, UK: Nature Publishing Group 10.1038/onc.2008.179

Fey, M F (2008). New insights into molecular mechanisms of haematological malignancies. Annals of oncology, 19 Suppl 5, v59-62. Oxford: Oxford University Press 10.1093/annonc/mdn312

Fey, M; Dreyling, M (2008). Acute myeloblastic leukemia in adult patients: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology, 19 Suppl 2, ii58-9. Oxford: Oxford University Press 10.1093/annonc/mdn089

Gruber, G; Cole, B F; Castiglione-Gertsch, M; Holmberg, S B; Lindtner, J; Golouh, R; Collins, J; Crivellari, D; Thürlimann, B; Simoncini, E; Fey, M F; Gelber, R D; Coates, A S; Price, K N; Goldhirsch, A; Viale, G; Gusterson, B A (2008). Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. Annals of oncology, 19(8), pp. 1393-401. Oxford: Oxford University Press 10.1093/annonc/mdn123

Fey, M F; Surbek, D (2008). Leukaemia and pregnancy. Recent results in cancer research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, 178, pp. 97-110. Berlin: Springer

Tschan, M P; Reddy, V A; Ress, A; Arvidsson, G; Fey, M F; Torbett, B E (2008). PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity. Oncogene, 27(24), pp. 3489-93. Basingstoke, UK: Nature Publishing Group 10.1038/sj.onc.1211004

Westermann, Dirk H; Schefer, Hubert; Thalmann, George N; Karamitopoulou-Diamantis, Evanthia; Fey, Martin F; Studer, Urs E (2008). Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis. Journal of urology, 179(1), pp. 163-6. New York, N.Y.: Elsevier 10.1016/j.juro.2007.08.172

Kuhn, A; Leupin, N; Fey, M.F.; Yousefi, S; Simon, H.U. (2008). Leukaemia cell lines are robust in vitro models - response to MacLeod & Drexler. British journal of haematology(142), pp. 138-141. Oxford: Wiley-Blackwell

Britschgi, Christian; Jenal, Mathias; Rizzi, Mattia; Mueller, Beatrice U; Torbett, Bruce E; Andres, Anne-Catherine; Tobler, Andreas; Fey, Martin F; Tschan, Mario P (2008). HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation. British journal of haematology, 141(2), pp. 179-87. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2008.06992.x

2007

Laurencet, F; Ballabeni, P; Rufener, B; Hess, U; Cerny, T; Fey, M; Luthi, JM; Plancherel, C; Zulian, GB; Swiss, Group for Clinical Research (SAKK) (2007). The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas. Acta haematologica, 117(1), pp. 40-7. Basel: Karger 10.1159/000096787

Wick, C; Egger, M; Trelle, S; Jüni, P; Fey, M F (2007). The characteristics of unsolicited clinical oncology literature provided by pharmaceutical industry. Annals of oncology, 18(9), pp. 1580-2. Oxford: Oxford University Press 10.1093/annonc/mdm402

Karlsson, Per; Cole, Bernard F; Price, Karen N; Coates, Alan S; Castiglione-Gertsch, Monica; Gusterson, Barry A; Murray, Elizabeth; Lindtner, Jurij; Collins, John P; Holmberg, Stig B; Fey, Martin F; Thürlimann, Beat; Crivellari, Diana; Forbes, John F; Gelber, Richard D; Goldhirsch, Aron; Wallgren, Arne (2007). The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. Journal of clinical oncology, 25(15), pp. 2019-26. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2006.09.8152

Rizzi, Mattia; Tschan, Mario P; Britschgi, Christian; Britschgi, Adrian; Hügli, Barbara; Grob, Tobias J; Leupin, Nicolas; Mueller, Beatrice U; Simon, Hans-Uwe; Ziemiecki, Andrew; Torbett, Bruce E; Fey, Martin F; Tobler, Andreas (2007). The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells. Journal of leukocyte biology, 81(6), pp. 1599-608. Bethesda, Md.: Society for Leukocyte Biology 10.1189/jlb.0606400

van den Heuvel-Eibrink, Marry M; van der Holt, Bronno; Burnett, Alan K; Knauf, Wolfgang U; Fey, Martin F; Verhoef, Gregor E G; Vellenga, Edo; Ossenkoppele, Gert J; Löwenberg, Bob; Sonneveld, Pieter (2007). CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age. Annals of hematology, 86(5), pp. 329-37. Berlin: Springer 10.1007/s00277-007-0269-7

Fey, M F (2007). Normal and malignant hematopoiesis. Annals of oncology, 18 Suppl 1, i9-i13. Oxford: Oxford University Press 10.1093/annonc/mdl444

Fey, M F (2007). Salient features of hematological diseases. Annals of oncology, 18 Suppl 1, i54-i64. Oxford: Oxford University Press 10.1093/annonc/mdl452

Tschan, M P; Gullberg, U; Shan, D; Torbett, B E; Fey, M F; Tobler, A (2007). The hDMP1 tumor suppressor is a new WT1 target in myeloid leukemias. Leukemia, 22(5), pp. 1087-1090. Basingstoke: Nature Publishing Group 10.1038/sj.leu.2405018

Fey, Martin (2007). Acute myeloblastic leukemia in adult patients: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of oncology, 18(suppl_2), ii47-ii48. Oxford University Press 10.1093/annonc/mdm033

2006

Dufour, Jean-François; Fey, Martin F (2006). What is the current treatment of PTLD after liver transplantation? Journal of hepatology, 44(1), pp. 23-6. Amsterdam: Elsevier 10.1016/j.jhep.2005.10.009

Martinelli, S; Kostylina, G; Niggli, V; Baumann, C; Fey, M F; Wendel, H-G; Lowe, S W; Yousefi, S; Simon, H-U (2006). Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophils. Oncogene, 25(52), pp. 6915-23. Basingstoke, UK: Nature Publishing Group 10.1038/sj.onc.1209692

Pestalozzi, BC; Zahrieh, D; Price, KN; Holmberg, SB; Lindtner, J; Collins, J; Crivellari, D; Fey, MF; Murray, E; Pagani, O; Simoncini, E; Castiglione-Gertsch, M; Gelber, RD; Coates, AS; Goldhirsch, A; International, Breast Cancer Study Group (IBCSG) (2006). Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Annals of oncology, 17(6), pp. 935-44. Oxford: Oxford University Press 10.1093/annonc/mdl064

Mueller, Beatrice U; Pabst, Thomas; Fos, José; Petkovic, Vibor; Fey, Martin F; Asou, Norio; Buergi, Ulrich; Tenen, Daniel G (2006). ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood, 107(8), pp. 3330-8. Washington, D.C.: American Society of Hematology 10.1182/blood-2005-07-3068

Mueller, B U; Buerger, A U; Solenthaler, M; Garamvoelgyi, E M; Oppliger-Leibundgut, E; Fey, M F; Pabst, T (2006). Pleural tumors as sole primary manifestation of acute promyelocytic leukemia. Annals of oncology, 17(4), pp. 722-3. Oxford: Oxford University Press 10.1093/annonc/mdj062

Leupin, Nicolas; Kuhn, Alexandre; Hügli, Barbara; Grob, Tobias J; Jaggi, Rolf; Tobler, Andreas; Delorenzi, Mauro; Fey, Martin F (2006). Gene expression profiling reveals consistent differences between clinical samples of human leukaemias and their model cell lines. British journal of haematology, 135(4), pp. 520-3. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2006.06342.x

Leyvraz, S; Herrmann, R; Guillou, L; Honegger, HP; Christinat, A; Fey, MF; Sessa, C; Wernli, M; Cerny, T; Dietrich, D; Pestalozzi, B; Swiss, Group for Clinical Cancer Research (SAKK) (2006). Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies. British journal of cancer, 95(10), pp. 1342-7. Basingstoke: Nature Publishing Group 10.1038/sj.bjc.6603420

Leyvraz, S; Zweifel, M; Jundt, G; Lissoni, A; Cerny, T; Sessa, C; Fey, M; Dietrich, D; Honegger, HP; Swiss, Group for Clinical Cancer Research (2006). Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomas. Annals of oncology, 17(4), pp. 646-51. Oxford: Oxford University Press 10.1093/annonc/mdl020

de Botton, S; Sanz, MA; Chevret, S; Dombret, H; Martin, G; Thomas, X; Mediavilla, JD; Recher, C; Ades, L; Quesnel, B; Brault, P; Fey, M; Wandt, H; Machover, D; Guerci, A; Maloisel, F; Stoppa, AM; Rayon, C; Ribera, JM; Chomienne, C; ... (2006). Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia, 20(1), pp. 35-41. Basingstoke: Nature Publishing Group 10.1038/sj.leu.2404006

Britschgi, C; Rizzi, M; Grob, T J; Tschan, M P; Hügli, B; Reddy, V A; Andres, Anne Catherine; Torbett, B E; Tobler, A; Fey, M F (2006). Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1. Oncogene, 25(14), pp. 2030-2039. Basingstoke, UK: Nature Publishing Group 10.1038/sj.onc.1209240

2005

Fey, M. F.; Greil, R.; Jost, L. M. (2005). ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients. Annals of oncology, 16(suppl_1), i48-i49. Oxford University Press 10.1093/annonc/mdi802

Fey, M. F. (2005). Principles of Molecular Oncology. Annals of oncology, 16(1), pp. 175-176. Oxford University Press 10.1093/annonc/mdi011

2004

Altznauer, Frank; Martinelli, Sibylla; Yousefi, Shida; Thürig, Christine; Schmid, Inès; Conway, Edward M; Schöni, Martin H; Vogt, Peter; Mueller, Christoph; Fey, Martin F; Zangemeister-Wittke, Uwe; Simon, Hans-Uwe (2004). Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. The Journal of experimental medicine, 199(10), pp. 1343-1354. Rockefeller Univ. Press 10.1084/jem.20032033

2003

Tschan, Mario; Fischer, K. M.; Fung, V. S.; Pirnia Borner, Farzaneh; Borner, Markus; Fey, Martin; Tobler, Andreas; Torbett, B. E. (2003). Alternative Splicing of the Human Cyclin D-binding Myb-like Protein (hDMP1) Yields a Truncated Protein Isoform That Alters Macrophage Differentiation Patterns. Journal of biological chemistry, 278(44), pp. 42750-42760. American Society for Biochemistry and Molecular Biology 10.1074/jbc.M307067200

Fey, M. F. (2003). ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of acute myeloblastic leukaemia (AML) in adult patients. Annals of oncology, 14(8), pp. 1161-1162. Oxford University Press 10.1093/annonc/mdg337

2002

Von Rohr, A.; Schmitz, S.-F. H.; Tichelli, A.; Hess, U.; Piguet, D.; Wernli, M.; Frickhofen, N.; Konwalinka, G.; Zulian, G.; Ghielmini, M.; Rufener, B.; Racine, C.; Fey, M. F.; Cerny, T.; Betticher, D.; Tobler, A. (2002). Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study. Annals of oncology, 13(10), pp. 1641-1649. Oxford University Press 10.1093/annonc/mdf272

Fey, M. F. (2002). The impact of chip technology on cancer medicine. Annals of oncology, 13(suppl 4), pp. 109-113. Oxford University Press 10.1093/annonc/mdf647

2001

Novak, Urban; Grob, T. J.; Baskaynak, G.; Peters, U. R.; Aebi, Stefan; Zwahlen, D.; Tschan, Mario; Kreuzer, K.-A.; Oppliger Leibundgut, Elisabeth; Cajot, J.-F.; Tobler, Andreas; Fey, Martin (2001). Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia. Annals of oncology, 12(7), pp. 981-986. Oxford University Press 10.1023/A:1011153206003

1999

Hasse, Urs; Tinguely, Marianne; Oppliger Leibundgut, Elisabeth; Cajot, Jean-François; Garvin, Alex M.; Tobler, Andreas; Borisch, Bettina; Fey, Martin F. (1999). Clonal Loss of Heterozygosity in Microdissected Hodgkin and Reed-Sternberg Cells. Journal of the National Cancer Institute JNCI, 91(18), pp. 1581-1583. Oxford University Press 10.1093/jnci/91.18.1581

Zahnd, D.; Aebi, S.; Rusterholz, S.; Fey, M. F.; Borner, M. M. (1999). A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devices. Annals of oncology, 10(6), pp. 727-729. Oxford University Press 10.1023/A:1008334313918

Peters, Uwe R; Hasse, Urs; Oppliger Leibundgut, Elisabeth; Tschan, Mario; Ong, S Tiong; Rassool, Feyruz V; Borisch, Bettina; Tobler, Andreas; Fey, Martin (1999). Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia. Oncogene, 18(1), pp. 79-85. Nature Publishing Group 10.1038/sj.onc.1202256

1998

Betticher, D. C.; Ratschiller, D.; Hsu Schmitz, S.-F.; Von Rohr, A.; Hess, U.; Zulian, G.; Wernli, M.; Tichelli, A.; Tobler, A.; Fey, M. F.; Cerny, T. (1998). Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Annals of oncology, 9(7), pp. 721-726. Oxford University Press 10.1023/A:1008273131598

Borner, M. M.; Castiglione, M.; Bacchi, M.; Weber, Walter; Herrmann, R.; Fey, M. F.; Pagani, O.; Leyvraz, S.; Morant, R.; Pestalozzi, B.; Hanselmann, S.; Goldhirsch, A. (1998). The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: Results of a phase III trial. Annals of oncology, 9(5), pp. 535-541. Oxford University Press 10.1023/A:1008270916325

1997

Goldhirsch, A.; Gelber, R. D.; Castiglione, M.; O'Neill, A.; Thürlimann, B.; Rudenstam, C.-M; Lindtner, J.; Collins, J.; Forbes, J.; Crivellari, D.; Coates, A.; Cavalli, F.; Simoncini, E.; Fey, M. F.; Pagani, O.; Price, K.; Senn, H.-J. (1997). Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: Results of the International Breast Cancer Study Group (IBCSG) Trial VI. Annals of oncology, 8(8), pp. 751-756. Oxford University Press 10.1023/A:1008220301866

1996

Fey, M. F.; Tobler, Andreas (1996). Tumour heterogeneity and clonality - an old theme revisited. Annals of oncology, 7(2), pp. 121-128. Oxford University Press 10.1093/oxfordjournals.annonc.a010537

Thürlimann, B.; Beretta, K.; Bacchi, M.; Castiglione-Gertsch, M.; Goldhirsch, A.; Jungi, W. F.; Cavalli, F.; Senn, H.-J.; Fey, M.; Löhnert, T. (1996). First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Annals of oncology, 7(5), pp. 471-479. Oxford University Press 10.1093/oxfordjournals.annonc.a010635

Nagel, S.; Borisch, B.; Von Rohr, A.; Tobler, Andreas; Fey, Martin (1996). Clonal analysis of a B-cell lymphoma with recurrent spontaneous remissions and evolution into chronic lymphocytic leukaemia. Annals of oncology, 7(9), pp. 953-960. Oxford University Press 10.1093/oxfordjournals.annonc.a010799

1994

Seitz, M.; Loetscher, P.; Fey, M. F.; Tobler, Andreas (1994). CONSTITUTIVE mRNA AND PROTEIN PRODUCTION OF MACROPHAGE COLONY-STIMULATING FACTOR BUT NOT OF OTHER CYTOKINES BY SYNOVIAL FIBROBLASTS FROM RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS PATIENTS. Rheumatology, 33(7), pp. 613-619. Oxford University Press 10.1093/rheumatology/33.7.613

Provide Feedback